The ability of GM-CSF to differentiate bone marrow cells into DCs in vitro is well characterized,9,11 as is its role in enhancing antigen presentation to T cells, thus supporting its potential utility as an adjuvant for TB vaccination.16,20,68,69 Its dual functions in both innate and adaptive immunity make GM-CSF a unique candidate in treating TB. Here, CSF2 is linked to tuberculosis.